This document discusses anticholinergic drugs, with a focus on atropine as the prototype drug. It describes how anticholinergic drugs act by blocking muscarinic acetylcholine receptors in the autonomic nervous system and central nervous system. Specifically, it summarizes atropine's pharmacological actions, including stimulating the CNS and heart rate, causing dilation of the pupils, relaxing smooth muscles, decreasing secretions from glands, and slightly raising body temperature. It also lists some common anticholinergic drugs and their uses, such as treating peptic ulcers, intestinal spasms, asthma, and as a pre-anesthetic medication.
cholingeric and Anticholinesterase drug in detail .this ppt contains introduction ,mechanism of action ,pharmacological action ,uses and adverse effect of the drug
cholingeric and Anticholinesterase drug in detail .this ppt contains introduction ,mechanism of action ,pharmacological action ,uses and adverse effect of the drug
A good read for undergraduate students in Pharmacy studying at the University of Mumbai. I will highly recommend Essentials of Medical Pharmacology by KD Tripathi. All copyright to the original authors and publishers.
introduction ,classification of cholinergic receptor ,and its function ,anti cholinergic agents -atropine and its pharmacology ,semi synthetic and synthetic atropine substitutes
THIS ppt explains in brief about general anesthesia for under graduates. It includes brief classification, mechanism of action, side effects of some important drugs. concepts like diffusion hypoxia, second gas effect, balanced anesthesia and pre- anaesthetic medication are discussed.
Need for Therapeutic Drug Monitoring, Factors to be considered during the Therapeutic Drug Monitoring, and Indian scenario for Therapeutic Drug Monitoring.
Drug distribution system in a hospital.pptxMangeshBansod2
Drug distribution system in a hospital
Dispensing of drugs to inpatients, types of drug distribution systems, charging policy and labelling, Dispensing of drugs to ambulatory patients, and Dispensing of controlled drugs.
Community Pharmacy
Organization and structure of retail and wholesale drug store, types and design, Legal requirements for establishment and maintenance of a drug store, Dispensing of proprietary products, maintenance of records of retail
and wholesale drug store
Adverse drug reaction- Drug Interaction .pptxMangeshBansod2
Classifications - Excessive pharmacological effects, secondary pharmacological effects, idiosyncrasy, allergic drug reactions, genetically determined toxicity, toxicity following sudden withdrawal of drugs, Drug interaction- beneficial interactions, adverse interactions, and pharmacokinetic drug interactions, Methods for detecting drug interactions,
spontaneous case reports and record linkage studies, and Adverse drug reaction reporting and management.
2. Hospital Pharmacy and its Organisation.pptxMangeshBansod2
Hospital pharmacy and its organization
Definition, functions of hospital pharmacy, Organization structure, Location, Layout and staff requirements, and Responsibilities and
functions of hospital pharmacists.
Hospital and it’s organization
Definition, Classification of hospital- Primary, Secondary and Tertiary hospitals, Classification based on clinical and non- clinical basis, Organization Structure of a Hospital, and Medical staffs involved in the
hospital and their functions.
Deep Behavioral Phenotyping in Systems Neuroscience for Functional Atlasing a...Ana Luísa Pinho
Functional Magnetic Resonance Imaging (fMRI) provides means to characterize brain activations in response to behavior. However, cognitive neuroscience has been limited to group-level effects referring to the performance of specific tasks. To obtain the functional profile of elementary cognitive mechanisms, the combination of brain responses to many tasks is required. Yet, to date, both structural atlases and parcellation-based activations do not fully account for cognitive function and still present several limitations. Further, they do not adapt overall to individual characteristics. In this talk, I will give an account of deep-behavioral phenotyping strategies, namely data-driven methods in large task-fMRI datasets, to optimize functional brain-data collection and improve inference of effects-of-interest related to mental processes. Key to this approach is the employment of fast multi-functional paradigms rich on features that can be well parametrized and, consequently, facilitate the creation of psycho-physiological constructs to be modelled with imaging data. Particular emphasis will be given to music stimuli when studying high-order cognitive mechanisms, due to their ecological nature and quality to enable complex behavior compounded by discrete entities. I will also discuss how deep-behavioral phenotyping and individualized models applied to neuroimaging data can better account for the subject-specific organization of domain-general cognitive systems in the human brain. Finally, the accumulation of functional brain signatures brings the possibility to clarify relationships among tasks and create a univocal link between brain systems and mental functions through: (1) the development of ontologies proposing an organization of cognitive processes; and (2) brain-network taxonomies describing functional specialization. To this end, tools to improve commensurability in cognitive science are necessary, such as public repositories, ontology-based platforms and automated meta-analysis tools. I will thus discuss some brain-atlasing resources currently under development, and their applicability in cognitive as well as clinical neuroscience.
This presentation explores a brief idea about the structural and functional attributes of nucleotides, the structure and function of genetic materials along with the impact of UV rays and pH upon them.
Cancer cell metabolism: special Reference to Lactate PathwayAADYARAJPANDEY1
Normal Cell Metabolism:
Cellular respiration describes the series of steps that cells use to break down sugar and other chemicals to get the energy we need to function.
Energy is stored in the bonds of glucose and when glucose is broken down, much of that energy is released.
Cell utilize energy in the form of ATP.
The first step of respiration is called glycolysis. In a series of steps, glycolysis breaks glucose into two smaller molecules - a chemical called pyruvate. A small amount of ATP is formed during this process.
Most healthy cells continue the breakdown in a second process, called the Kreb's cycle. The Kreb's cycle allows cells to “burn” the pyruvates made in glycolysis to get more ATP.
The last step in the breakdown of glucose is called oxidative phosphorylation (Ox-Phos).
It takes place in specialized cell structures called mitochondria. This process produces a large amount of ATP. Importantly, cells need oxygen to complete oxidative phosphorylation.
If a cell completes only glycolysis, only 2 molecules of ATP are made per glucose. However, if the cell completes the entire respiration process (glycolysis - Kreb's - oxidative phosphorylation), about 36 molecules of ATP are created, giving it much more energy to use.
IN CANCER CELL:
Unlike healthy cells that "burn" the entire molecule of sugar to capture a large amount of energy as ATP, cancer cells are wasteful.
Cancer cells only partially break down sugar molecules. They overuse the first step of respiration, glycolysis. They frequently do not complete the second step, oxidative phosphorylation.
This results in only 2 molecules of ATP per each glucose molecule instead of the 36 or so ATPs healthy cells gain. As a result, cancer cells need to use a lot more sugar molecules to get enough energy to survive.
Unlike healthy cells that "burn" the entire molecule of sugar to capture a large amount of energy as ATP, cancer cells are wasteful.
Cancer cells only partially break down sugar molecules. They overuse the first step of respiration, glycolysis. They frequently do not complete the second step, oxidative phosphorylation.
This results in only 2 molecules of ATP per each glucose molecule instead of the 36 or so ATPs healthy cells gain. As a result, cancer cells need to use a lot more sugar molecules to get enough energy to survive.
introduction to WARBERG PHENOMENA:
WARBURG EFFECT Usually, cancer cells are highly glycolytic (glucose addiction) and take up more glucose than do normal cells from outside.
Otto Heinrich Warburg (; 8 October 1883 – 1 August 1970) In 1931 was awarded the Nobel Prize in Physiology for his "discovery of the nature and mode of action of the respiratory enzyme.
WARNBURG EFFECT : cancer cells under aerobic (well-oxygenated) conditions to metabolize glucose to lactate (aerobic glycolysis) is known as the Warburg effect. Warburg made the observation that tumor slices consume glucose and secrete lactate at a higher rate than normal tissues.
Introduction:
RNA interference (RNAi) or Post-Transcriptional Gene Silencing (PTGS) is an important biological process for modulating eukaryotic gene expression.
It is highly conserved process of posttranscriptional gene silencing by which double stranded RNA (dsRNA) causes sequence-specific degradation of mRNA sequences.
dsRNA-induced gene silencing (RNAi) is reported in a wide range of eukaryotes ranging from worms, insects, mammals and plants.
This process mediates resistance to both endogenous parasitic and exogenous pathogenic nucleic acids, and regulates the expression of protein-coding genes.
What are small ncRNAs?
micro RNA (miRNA)
short interfering RNA (siRNA)
Properties of small non-coding RNA:
Involved in silencing mRNA transcripts.
Called “small” because they are usually only about 21-24 nucleotides long.
Synthesized by first cutting up longer precursor sequences (like the 61nt one that Lee discovered).
Silence an mRNA by base pairing with some sequence on the mRNA.
Discovery of siRNA?
The first small RNA:
In 1993 Rosalind Lee (Victor Ambros lab) was studying a non- coding gene in C. elegans, lin-4, that was involved in silencing of another gene, lin-14, at the appropriate time in the
development of the worm C. elegans.
Two small transcripts of lin-4 (22nt and 61nt) were found to be complementary to a sequence in the 3' UTR of lin-14.
Because lin-4 encoded no protein, she deduced that it must be these transcripts that are causing the silencing by RNA-RNA interactions.
Types of RNAi ( non coding RNA)
MiRNA
Length (23-25 nt)
Trans acting
Binds with target MRNA in mismatch
Translation inhibition
Si RNA
Length 21 nt.
Cis acting
Bind with target Mrna in perfect complementary sequence
Piwi-RNA
Length ; 25 to 36 nt.
Expressed in Germ Cells
Regulates trnasposomes activity
MECHANISM OF RNAI:
First the double-stranded RNA teams up with a protein complex named Dicer, which cuts the long RNA into short pieces.
Then another protein complex called RISC (RNA-induced silencing complex) discards one of the two RNA strands.
The RISC-docked, single-stranded RNA then pairs with the homologous mRNA and destroys it.
THE RISC COMPLEX:
RISC is large(>500kD) RNA multi- protein Binding complex which triggers MRNA degradation in response to MRNA
Unwinding of double stranded Si RNA by ATP independent Helicase
Active component of RISC is Ago proteins( ENDONUCLEASE) which cleave target MRNA.
DICER: endonuclease (RNase Family III)
Argonaute: Central Component of the RNA-Induced Silencing Complex (RISC)
One strand of the dsRNA produced by Dicer is retained in the RISC complex in association with Argonaute
ARGONAUTE PROTEIN :
1.PAZ(PIWI/Argonaute/ Zwille)- Recognition of target MRNA
2.PIWI (p-element induced wimpy Testis)- breaks Phosphodiester bond of mRNA.)RNAse H activity.
MiRNA:
The Double-stranded RNAs are naturally produced in eukaryotic cells during development, and they have a key role in regulating gene expression .
What is greenhouse gasses and how many gasses are there to affect the Earth.moosaasad1975
What are greenhouse gasses how they affect the earth and its environment what is the future of the environment and earth how the weather and the climate effects.
Seminar of U.V. Spectroscopy by SAMIR PANDASAMIR PANDA
Spectroscopy is a branch of science dealing the study of interaction of electromagnetic radiation with matter.
Ultraviolet-visible spectroscopy refers to absorption spectroscopy or reflect spectroscopy in the UV-VIS spectral region.
Ultraviolet-visible spectroscopy is an analytical method that can measure the amount of light received by the analyte.
Multi-source connectivity as the driver of solar wind variability in the heli...Sérgio Sacani
The ambient solar wind that flls the heliosphere originates from multiple
sources in the solar corona and is highly structured. It is often described
as high-speed, relatively homogeneous, plasma streams from coronal
holes and slow-speed, highly variable, streams whose source regions are
under debate. A key goal of ESA/NASA’s Solar Orbiter mission is to identify
solar wind sources and understand what drives the complexity seen in the
heliosphere. By combining magnetic feld modelling and spectroscopic
techniques with high-resolution observations and measurements, we show
that the solar wind variability detected in situ by Solar Orbiter in March
2022 is driven by spatio-temporal changes in the magnetic connectivity to
multiple sources in the solar atmosphere. The magnetic feld footpoints
connected to the spacecraft moved from the boundaries of a coronal hole
to one active region (12961) and then across to another region (12957). This
is refected in the in situ measurements, which show the transition from fast
to highly Alfvénic then to slow solar wind that is disrupted by the arrival of
a coronal mass ejection. Our results describe solar wind variability at 0.5 au
but are applicable to near-Earth observatories.
Comparing Evolved Extractive Text Summary Scores of Bidirectional Encoder Rep...University of Maribor
Slides from:
11th International Conference on Electrical, Electronics and Computer Engineering (IcETRAN), Niš, 3-6 June 2024
Track: Artificial Intelligence
https://www.etran.rs/2024/en/home-english/
2. ANTICHOLINERGIC DRUGS
(Muscarinic receptor antagonists,
Atropinic, Parasympatholytic)
The term ‘anticholinergic drugs’ is restricted to those which block
actions of Ach on autonomic effectors and in the CNS exerted
through muscarinic receptors.
Nicotinic receptor antagonists also block certain actions of
ACh, they are generally referred to as ‘ganglion
blockers’ and ‘neuromuscular blockers’.
Atropine, the prototype drug of this class, is highly selective for
muscarinic receptors
3.
4. PHARMACOLOGICAL ACTIONS(Atropine as prototype)
1. CNS - Atropine has an overall CNS stimulant action.
• Atropine stimulates many medullary centres —vagal, respiratory, vasomotor.
• It depresses vestibular excitation and has antimotion sickness property.
probably there is a cholinergic link in the vestibular pathway, or it may be
exerted at the cortical level.
• By blocking the relative cholinergic overactivity in basal ganglia, it suppresses
tremor and rigidity of parkinsonism.
• High doses cause cortical excitation, restlessness, disorientation,
hallucinations and delirium followed by respiratory depression and coma.
5. 2. CVS – Heart- The most prominent effect of
atropine is tachycardia. It is due to blockade of
M2 receptors on the SA node through which
vagal tone decreases HR.
3. Eye - Topical instillation of atropine causes
mydriasis, abolition of light reflex
and cycloplegia lasting 7–10 days.This results
in photophobia and blurring of near vision
PHARMACOLOGICAL ACTIONS(Atropine as prototype)
6. 4. Smooth muscles - All visceral smooth muscles that receive
parasympathetic motor innervation are relaxed by atropine (M3
blockade).
Tone and amplitude of contractions of stomach and intestine are
reduced; the passage of chyme is slowed—constipation may occur,
spasm may be relieved.
Atropine causes bronchodilatation and reduces airway resistance,
especially in COPD and asthma patients.
Atropine has relaxant action on ureter and urinary bladder; urinary
retention can occur in older males with prostatic hypertrophy.
PHARMACOLOGICAL ACTIONS(Atropine as prototype)
7. 5. Glands - Atropine markedly decreases sweat, salivary,
tracheobronchial and lacrimal secretion (M3 blockade). Skin and eyes
become dry, talking and swallowing may be difficult.
Atropine decreases secretion of acid, pepsin and mucus in the
stomach
6. Body temperature - Rise in body temperature occurs at higher
doses. It is due to both inhibition of sweating as well as stimulation of
temperature regulating centre in the hypothalamus.
7. Local anaesthetic - Atropine has a mild anaesthetic action on the
cornea.
PHARMACOLOGICAL ACTIONS(Atropine as prototype)
8. Ipratropium bromide - ipratropium is effective in COPD
Propantheline -it was a popular anticholinergic drug used for peptic ulcer and
gastritis.
Oxyphenonium -similar to propantheline, recommended for
peptic ulcer and gastrointestinal hypermotility
Clidinium -antisecretoryantispasmodic has been used in combination with
benzodiazepines for nervous dyspepsia, gastritis, irritable bowel syndrome, colic,
peptic ulcer, etc.
Isopropamide -indicated in hyperacidity, nervous dyspepsia, irritable bowel
and other gastrointestinal problems
Dicyclomine - It exerts antispasmodic action , Dysmenorrhoea and irritable bowel are
other indications
ATROPINE SUBSTITUTES
9. Oxybutynin - This newer antimuscarinic has high affinity for receptors
in urinary bladder and salivary glands alongwith additional smooth
muscle relaxant and local anaesthetic properties.
Because of vasicoselective action, it is used for detrusor
instability resulting in urinary frequency and urge incontinence.
Beneficial effects have been demonstrated in post-prostatectomy
vasical spasm, neurogenic bladder, spina bifida and nocturnal
enuresis.
Vasicoselective drugs
10. Mydriatics
Atropine is a potent mydriatic but its slow and
long-lasting action is undesirable for refraction testing.
Tropicamide- It has the quickest (20–40 min) and briefest (3–6
hours) action, but is a relatively unreliable cycloplegic.
11. USES
I. As antisecretory
1. Preanaesthetic medication - When irritant general anaesthetics (ether) were used, prior
administration of anticholinergics (atropine,
hyoscine, glycopyrrolate) was imperative to check increased salivary and
tracheobronchial secretions.
2. Peptic ulce
II. As antispasmodic –
1. Intestinal and renal colic, abdominal cramps:
symptomatic relief
2. Nervous, functional and drug induced diarrhoea
3. Spastic constipation, irritable bowel syndrome:
4.To relieve urinary frequency and urgency, enuresis in children
III. Bronchial asthma, asthmatic- bronchitis, COPD
IV. As mydriatic and cycloplegic
12. USES
V. For central action
1. Parkinsonism
2. Motion sickness
VI.To antagonise muscarinic effects of drugs and poisons